Showing results (1921-1930 of 3,593) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|December 1, 2020
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patientsAlkistis Papatheodoridi, Antonios Chatzigeorgiou, Lampros Chrysavgis, et al.Journal of Viral Hepatitis|December 4, 2020
The impact of hepatitis flare on HBeAg loss was effective mainly in the first year of Nucleot(s)ide therapy in chronic hepatitis BChien-Wei Peng, Wen-Juei Jeng, Rong-Nan Chien, et al.Journal of Viral Hepatitis|December 10, 2020
Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysisMyrte Gorris, Bernice M van der Lecq, Karel J van Erpecum, et al.Journal of Viral Hepatitis|December 11, 2020
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysisCori Campbell, Tingyan Wang, Anna L McNaughton, et al.Journal of Viral Hepatitis|December 11, 2020
Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBVZobair M Younossi, Maria Stepanova, Issah Younossi, et al.Journal of Viral Hepatitis|December 11, 2020
Hepatitis E-Associated Hospitalizations in the United States: 2010-2015 and 2015-2017Paul Wasuwanich, Thammasin Ingviya, Supharerk Thawillarp, et al.Journal of Viral Hepatitis|December 11, 2020
Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosisTakashi Kumada, Hidenori Toyoda, Satoshi Yasuda, et al.Journal of Viral Hepatitis|March 14, 2018
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic reviewN Goossens, C de Vito, A Mangia, et al.Journal of Viral Hepatitis|March 15, 2021
Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infectionJoy J Jiang, Meredith S Shiels, Thomas R O'BrienJournal of Viral Hepatitis|March 15, 2021
Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failureDamir Garcia-Cehic, Ariadna Rando, Francisco Rodriguez-Frias, et al.Pageof 360